Spotlight

Prof Andrew Morris

Spotlight on: Professor Andrew Morris

Spotlight on: Professor Andrew Morris Professor Andrew Morris is the inaugural Director of Health Data Research UK (HDR UK). He is seconded from his position as Professor of Medicine, and Vice Principal of Data Science at the University of Edinburgh. Prior to this Andrew was Dean of Medicine at the University of Dundee and Chief Scientist at the Scottish Government (2012-2017).  His research interests span informatics and chronic diseases.  Here,… Read More »Spotlight on: Professor Andrew Morris

Spotlight on: Emma Lawrence

Spotlight on: Emma Lawrence In our latest blog post we meet Engagement Manager, Research, Dr Emma Lawrence to find out more about her role and future work at the UKCRC Tissue Directory and Coordination Centre (UKCRC TDCC). What is your role and what does it involve? My job title is Engagement Manager for Research. It’s my job to make sure that the UKCRC Tissue Directory is as useful and relevant… Read More »Spotlight on: Emma Lawrence

Spotlight on: Gautam Mehta

Spotlight on: Gautam Mehta Job title: Honorary Consultant and Senior Lecturer, UCL Research Project: Gautam is exploring new ways to treat patients with liver failure and alcohol-related liver disease. Liver disease is the third commonest cause of preventable death in the UK and rates are rising rapidly, therefore new treatments are urgently needed. Gautam’s research involves sequencing RNA (part of the genetic code of cells) from human liver and immune cells… Read More »Spotlight on: Gautam Mehta

Ana's photo

Spotlight on: Ana Rio-Machin

Spotlight on: Ana Rio-Machin Job title: Postdoctoral Researcher at Barts Cancer Institute (BCI), Queen Mary University of London Research Project: Ana researches the genetic alterations (mutations) that are inherited in families who have leukaemia without a known cause, within a Bloodwise funded programme; ‘Acute Myeloid Leukaemia (AML) familial cases, where two or more affected individuals are found in the same family, are rare but represent a high-risk group of patients… Read More »Spotlight on: Ana Rio-Machin